Skip to main content
. 2024 Oct 31;24(21):7042. doi: 10.3390/s24217042

Figure 11.

Figure 11

Scheme of an FO process with MNPs as the DS for the concentration of active pharmaceutical ingredients in the pharmaceutical industry.